TipRanks
Verastem (VSTM)
NASDAQ:VSTM
US Market
VSTM
Verastem
RESEARCH TOOLSreports
Want to see VSTM full AI Analyst Report?

Verastem (VSTM) Stock Forecast & Price Target

2,112 Followers
See the Price Targets and Ratings of:

VSTM Analyst Ratings

Strong Buy
7Ratings
Strong Buy
7 Buy
0 Hold
0 Sell
Based on 7 analysts giving stock ratings to
Verastem
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

VSTM Stock 12 Month Forecast

Average Price Target

$18.17
▲(156.59% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for Verastem in the last 3 months. The average price target is $18.17 with a high forecast of $24.00 and a low forecast of $12.00. The average price target represents a 156.59% change from the last price of $7.08.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3":"$3","14":"$14","25":"$25","8.5":"$8.5","19.5":"$19.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":24,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$24.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":18.166666666666668,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$18.17</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":12,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$12.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3,8.5,14,19.5,25],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.9,9.138461538461538,10.376923076923077,11.615384615384617,12.853846153846154,14.092307692307692,15.330769230769231,16.56923076923077,17.807692307692307,19.04615384615385,20.284615384615385,21.52307692307692,22.761538461538464,{"y":24,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.9,8.68974358974359,9.47948717948718,10.26923076923077,11.05897435897436,11.84871794871795,12.63846153846154,13.428205128205128,14.217948717948719,15.00769230769231,15.797435897435898,16.58717948717949,17.376923076923077,{"y":18.166666666666668,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.9,8.215384615384616,8.53076923076923,8.846153846153847,9.161538461538463,9.476923076923077,9.792307692307693,10.107692307692307,10.423076923076923,10.73846153846154,11.053846153846154,11.36923076923077,11.684615384615384,{"y":12,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":8.8,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.45,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.34,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.72,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.25,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.82,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.55,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.84,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.19,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.1,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.8,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.61,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.9,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$24.00Average Price Target$18.17Lowest Price Target$12.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on VSTM
Andres Y. Maldonado
H.C. Wainwright
H.C. Wainwright
$18
Buy
154.24%
Upside
Reiterated
10/16/26
Analysts' Top Healthcare Picks: Praxis Precision Medicines (PRAX), Verastem (VSTM)
Mizuho Securities Analyst forecast on VSTM
Graig Suvannavejh
Mizuho Securities
Mizuho Securities
$13→$14
Buy
97.74%
Upside
Reiterated
10/16/26
Verastem price target raised to $14 from $13 at MizuhoVerastem price target raised to $14 from $13 at Mizuho
RBC Capital Analyst forecast on VSTM
Leonid Timashev
RBC Capital
RBC Capital
$14→$19
Buy
168.36%
Upside
Assigned
10/15/26
RBC Capital Reaffirms Their Buy Rating on Verastem (VSTM)
BTIG Analyst forecast on VSTM
Jeet Mukherjee
BTIG
BTIG
$24
Buy
238.98%
Upside
Reiterated
10/15/26
Analysts' Top Healthcare Picks: Verastem (VSTM), Rezolute (RZLT)
Alliance Global Partners Analyst forecast on VSTM
Matthew Venezia
Alliance Global Partners
Alliance Global Partners
$18→$22
Buy
210.73%
Upside
Reiterated
10/15/26
Verastem price target raised to $22 from $18 at Alliance GlobalVerastem price target raised to $22 from $18 at Alliance Global
Wolfe Research Analyst forecast on VSTM
Kalpit Patel
Wolfe Research
Wolfe Research
―
Buy
―
Initiated
09/17/26
Verastem initiated with an Outperform at Wolfe ResearchVerastem initiated with an Outperform at Wolfe Research
Guggenheim Analyst forecast on VSTM
Michael Schmidt
Guggenheim
Guggenheim
$14→$12
Buy
69.49%
Upside
Reiterated
08/06/26
Verastem price target lowered to $12 from $14 at GuggenheimVerastem price target lowered to $12 from $14 at Guggenheim
Jefferies Analyst forecast on VSTM
Faisal Khurshid
Jefferies
Jefferies
$15→$8
Buy
12.99%
Upside
Reiterated
06/23/26
Verastem price target lowered to $8 from $15 at JefferiesVerastem price target lowered to $8 from $15 at Jefferies
B. Riley Securities Analyst forecast on VSTM
Unknown Analyst
B. Riley Securities
Not Ranked
B. Riley Securities
$16
Buy
125.99%
Upside
Initiated
05/22/26
Verastem (VSTM) Receives a Buy from B. Riley Securities
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on VSTM
Andres Y. Maldonado
H.C. Wainwright
H.C. Wainwright
$18
Buy
154.24%
Upside
Reiterated
10/16/26
Analysts' Top Healthcare Picks: Praxis Precision Medicines (PRAX), Verastem (VSTM)
Mizuho Securities Analyst forecast on VSTM
Graig Suvannavejh
Mizuho Securities
Mizuho Securities
$13→$14
Buy
97.74%
Upside
Reiterated
10/16/26
Verastem price target raised to $14 from $13 at MizuhoVerastem price target raised to $14 from $13 at Mizuho
RBC Capital Analyst forecast on VSTM
Leonid Timashev
RBC Capital
RBC Capital
$14→$19
Buy
168.36%
Upside
Assigned
10/15/26
RBC Capital Reaffirms Their Buy Rating on Verastem (VSTM)
BTIG Analyst forecast on VSTM
Jeet Mukherjee
BTIG
BTIG
$24
Buy
238.98%
Upside
Reiterated
10/15/26
Analysts' Top Healthcare Picks: Verastem (VSTM), Rezolute (RZLT)
Alliance Global Partners Analyst forecast on VSTM
Matthew Venezia
Alliance Global Partners
Alliance Global Partners
$18→$22
Buy
210.73%
Upside
Reiterated
10/15/26
Verastem price target raised to $22 from $18 at Alliance GlobalVerastem price target raised to $22 from $18 at Alliance Global
Wolfe Research Analyst forecast on VSTM
Kalpit Patel
Wolfe Research
Wolfe Research
―
Buy
―
Initiated
09/17/26
Verastem initiated with an Outperform at Wolfe ResearchVerastem initiated with an Outperform at Wolfe Research
Guggenheim Analyst forecast on VSTM
Michael Schmidt
Guggenheim
Guggenheim
$14→$12
Buy
69.49%
Upside
Reiterated
08/06/26
Verastem price target lowered to $12 from $14 at GuggenheimVerastem price target lowered to $12 from $14 at Guggenheim
Jefferies Analyst forecast on VSTM
Faisal Khurshid
Jefferies
Jefferies
$15→$8
Buy
12.99%
Upside
Reiterated
06/23/26
Verastem price target lowered to $8 from $15 at JefferiesVerastem price target lowered to $8 from $15 at Jefferies
B. Riley Securities Analyst forecast on VSTM
Unknown Analyst
B. Riley Securities
Not Ranked
B. Riley Securities
$16
Buy
125.99%
Upside
Initiated
05/22/26
Verastem (VSTM) Receives a Buy from B. Riley Securities
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
KNSAKiniksa Pharmaceuticals
OMCLOmnicell
AXGNAxoGen
ONCBeOne Medicines
AHCOAdaptHealth
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Verastem

3 Months
Leonid TimashevRBC Capital
Success Rate
9/15 ratings generated profit
60%
Average Return
+26.80%
Copying Leonid Timashev's trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +26.80% per trade.
1 Year
Leonid TimashevRBC Capital
Success Rate
13/15 ratings generated profit
87%
Average Return
+37.83%
Copying Leonid Timashev's trades and holding each position for 1 Year would result in 86.67% of your transactions generating a profit, with an average return of +37.83% per trade.
2 Years
Leonid TimashevRBC Capital
Success Rate
15/15 ratings generated profit
100%
Average Return
+56.43%
Copying Leonid Timashev's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +56.43% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

VSTM Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
22
19
15
9
17
Buy
0
0
0
1
1
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
22
19
15
10
18
In the current month, VSTM has received 18 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. VSTM average Analyst price target in the past 3 months is 18.17.
Each month's total comprises the sum of three months' worth of ratings.

VSTM Financial Forecast

VSTM Earnings Forecast

Next quarter’s earnings estimate for VSTM is -$0.47 with a range of -$0.60 to -$0.37. The previous quarter’s EPS was -$0.35. VSTM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year VSTM has Performed in-line its overall industry.
Next quarter’s earnings estimate for VSTM is -$0.47 with a range of -$0.60 to -$0.37. The previous quarter’s EPS was -$0.35. VSTM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year VSTM has Performed in-line its overall industry.

VSTM Sales Forecast

Next quarter’s sales forecast for VSTM is $26.57M with a range of $24.00M to $31.00M. The previous quarter’s sales results were $40.08M. VSTM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year VSTM has Performed in-line its overall industry.
Next quarter’s sales forecast for VSTM is $26.57M with a range of $24.00M to $31.00M. The previous quarter’s sales results were $40.08M. VSTM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year VSTM has Performed in-line its overall industry.

VSTM Stock Forecast FAQ

What is VSTM’s average 12-month price target, according to analysts?
Based on analyst ratings, Verastem’s 12-month average price target is 18.17.
    What is VSTM’s upside potential, based on the analysts’ average price target?
    Verastem has 156.59% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is VSTM a Buy, Sell or Hold?
          Verastem has a consensus rating of Strong Buy which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Verastem’s price target?
            The average price target for Verastem is 18.17. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $24.00 ,the lowest forecast is $12.00. The average price target represents 156.59% Increase from the current price of $7.08.
              What do analysts say about Verastem?
              Verastem’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of VSTM?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.